약제용출 풍선 시장 : 유형, 코팅 기술, 최종사용자별 - 세계 예측(2025-2030년)

The Drug Eluting Balloon Market was valued at USD 965.84 million in 2023, expected to reach USD 1,098.31 million in 2024, and is projected to grow at a CAGR of 15.51%, to USD 2,650.47 million by 2030.

A Drug Eluting Balloon (DEB) is a medical device used primarily in the field of interventional cardiology. It combines the mechanical feature of a traditional angioplasty balloon with the pharmaceutical benefits of drug elution, providing an innovative solution for treating vascular diseases. The DEB market is driven by the rising prevalence of cardiovascular diseases, increasing awareness regarding minimally invasive procedures, and technological advancements in healthcare devices. Crucial to its application are the treatments for coronary artery disease and peripheral artery disease, addressing restenosis by delivering anti-proliferative drugs directly to the affected site. End-use scope includes hospitals, ambulatory surgical centers, and specialized clinics, significantly driving the demand for DEBs.

The market shows promising growth potential, fueled by the increasing global aging population and subsequent rise in chronic disease occurrences. Potential opportunities can be harnessed through innovative product designs focusing on improved drug formulations and user-friendly delivery mechanisms. Further market expansion can be achieved by entering emerging markets where healthcare infrastructure is progressively improving. However, stringent regulatory landscapes and high costs of procedure and product development are key limitations. Technical challenges such as balloon slippage and inconsistent drug delivery also hinder growth.

Innovation should be directed towards enhancing the efficacy of drug release and expanding the range of drugs that can be delivered via DEBs. Developing solutions to overcome technical barriers and improving the cost-effectiveness of production are areas ripe for research. Collaborations between device manufacturers and pharmaceutical companies could foster new product developments. The market remains dynamic, with a strong competitive environment encouraging continuous growth and adaptation. By addressing these challenges through targeted research and strategic collaborations, stakeholders can significantly influence the trajectory of the DEB market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Eluting Balloon Market

The Drug Eluting Balloon Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Geriatric Population Leading to Cardiovascular Diseases
  • Rising Prevalence of Peripheral and Coronary Artery Diseases
  • Favorable Approvals to Support the Growth of DEBs
• Market Restraints
  • Issues Associated to Product Recalls of Drug-Eluting Balloons
• Market Opportunities
  • New Developments in the Clinical Use of Drug-Coated Balloon Catheters
  • Advancement, Innovation, and Research in Drug-Coated Balloons
• Market Challenges
  • Lack of Availability for Skilled and Trained Professionals

Porter's Five Forces: A Strategic Tool for Navigating the Drug Eluting Balloon Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Eluting Balloon Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Eluting Balloon Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Eluting Balloon Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Eluting Balloon Market

A detailed market share analysis in the Drug Eluting Balloon Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Eluting Balloon Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Eluting Balloon Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Drug Eluting Balloon Market, highlighting leading vendors and their innovative profiles. These include Medtronic PLC, Becton, Dickinson and Company, Boston Scientific Corporation, M.A. Med Alliance SA by Cordis Corporation, Eurocor Tech GmbH, Lepu Medical Technology, Invamed, Biotronik SE & Co. KG, Cook Medical, Inc., Terumo Corporation, Cardionovum GmbH, SurModics, Inc., Johnson & Johnson Services, Inc., Balton Sp. z o. o., B. Braun Melsungen AG, Bayer AG, Abbott Laboratories, Wellinq, Laborie Medical Technologies, Inc., Concept Medical, Zylox-Tonbridge Medical Technology Co., Ltd., Biosensors International Group, Ltd., Koninklijke Philips N.V., and iVascular S.L.U..

Market Segmentation & Coverage

This research report categorizes the Drug Eluting Balloon Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Coronary Drug Eluting Balloon and Peripheral Drug Eluting Balloon.
• Based on Coating Technology, market is studied across EnduraCoat, FreePac, Paccocath, and TransPax.
• Based on End User, market is studied across Ambulatory Surgery Centers, Cath Labs, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Geriatric Population Leading to Cardiovascular Diseases
    • 5.1.1.2. Rising Prevalence of Peripheral and Coronary Artery Diseases
    • 5.1.1.3. Favorable Approvals to Support the Growth of DEBs
  • 5.1.2. Restraints
    • 5.1.2.1. Issues Associated to Product Recalls of Drug-Eluting Balloons
  • 5.1.3. Opportunities
    • 5.1.3.1. New Developments in the Clinical Use of Drug-Coated Balloon Catheters
    • 5.1.3.2. Advancement, Innovation, and Research in Drug-Coated Balloons
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of Availability for Skilled and Trained Professionals
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Significance of coronary DEBs in enhancing deliverability and drug transfer
  • 5.2.2. Coating Technology: Growing preferences for enduraCoat with better local drug release profile
  • 5.2.3. End User: Higher adoption of DEBs in Cath Labs owing to ease of use and speed of the procedure
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Drug Eluting Balloon Market, by Type

• 6.1. Introduction
• 6.2. Coronary Drug Eluting Balloon
• 6.3. Peripheral Drug Eluting Balloon

7. Drug Eluting Balloon Market, by Coating Technology

• 7.1. Introduction
• 7.2. EnduraCoat
• 7.3. FreePac
• 7.4. Paccocath
• 7.5. TransPax

8. Drug Eluting Balloon Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgery Centers
• 8.3. Cath Labs
• 8.4. Hospitals

9. Americas Drug Eluting Balloon Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Drug Eluting Balloon Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Drug Eluting Balloon Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Advanced NanoTherapies (ANT) Secures USD 4 Million Strategic Investment to Accelerate Clinical Development of SirPlux Duo Drug-Coated Balloon (DCB) for Treating de novo Coronary Artery Disease (CAD)
  • 12.3.2. Translumina further Strengthens Its Technology Portfolio with Acquisition of Blue Medical Devices, Netherlands
  • 12.3.3. Surmodics Receives FDA Approval for the SurVeil Drug-Coated Balloon

Companies Mentioned

• 1. Medtronic PLC
• 2. Becton, Dickinson and Company
• 3. Boston Scientific Corporation
• 4. M.A. Med Alliance SA by Cordis Corporation
• 5. Eurocor Tech GmbH
• 6. Lepu Medical Technology
• 7. Invamed
• 8. Biotronik SE & Co. KG
• 9. Cook Medical, Inc.
• 10. Terumo Corporation
• 11. Cardionovum GmbH
• 12. SurModics, Inc.
• 13. Johnson & Johnson Services, Inc.
• 14. Balton Sp. z o. o.
• 15. B. Braun Melsungen AG
• 16. Bayer AG
• 17. Abbott Laboratories
• 18. Wellinq
• 19. Laborie Medical Technologies, Inc.
• 20. Concept Medical
• 21. Zylox-Tonbridge Medical Technology Co., Ltd.
• 22. Biosensors International Group, Ltd.
• 23. Koninklijke Philips N.V.
• 24. iVascular S.L.U.